HTG Molecular Diagnostics Stock Price, News & Analysis (NASDAQ:HTGM)

$1.89 0.00 (0.00 %)
(As of 12/10/2017 04:00 PM ET)
Previous Close$1.89
Today's Range$1.87 - $1.93
52-Week Range$1.20 - $13.25
Volume238,354 shs
Average Volume281,508 shs
Market Capitalization$23.63 million
P/E RatioN/A
Dividend YieldN/A
Beta0.79

About HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics logoHTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.

Receive HTGM News and Ratings via Email

Sign-up to receive the latest news and ratings for HTGM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Diagnostic & Testing Equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:HTGM
CUSIPN/A
Phone877-289-2615

Debt

Debt-to-Equity RatioN/A
Current Ratio1.03%
Quick Ratio0.94%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.13 million
Price / Sales4.61
Cash FlowN/A
Price / CashN/A
Book Value($0.79) per share
Price / Book-2.39

Profitability

Trailing EPS($2.55)
Net Income$-26,030,000.00
Net Margins-273.17%
Return on EquityN/A
Return on Assets-136.22%

Miscellaneous

Employees85
Outstanding Shares12,510,000

HTG Molecular Diagnostics (NASDAQ:HTGM) Frequently Asked Questions

What is HTG Molecular Diagnostics' stock symbol?

HTG Molecular Diagnostics trades on the NASDAQ under the ticker symbol "HTGM."

How were HTG Molecular Diagnostics' earnings last quarter?

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) announced its quarterly earnings data on Tuesday, August, 8th. The medical research company reported ($0.60) earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.60). The medical research company earned $1.76 million during the quarter, compared to analyst estimates of $1.80 million. View HTG Molecular Diagnostics' Earnings History.

Where is HTG Molecular Diagnostics' stock going? Where will HTG Molecular Diagnostics' stock price be in 2017?

3 equities research analysts have issued 1 year target prices for HTG Molecular Diagnostics' shares. Their forecasts range from $6.00 to $6.50. On average, they expect HTG Molecular Diagnostics' stock price to reach $6.17 in the next twelve months. View Analyst Ratings for HTG Molecular Diagnostics.

What are Wall Street analysts saying about HTG Molecular Diagnostics stock?

Here are some recent quotes from research analysts about HTG Molecular Diagnostics stock:

  • 1. According to Zacks Investment Research, "HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona. " (11/15/2017)
  • 2. HC Wainwright analysts commented, "We note that the launch of this new assay comes on schedule and expands the company’s existing menu following the launch of HTG EdgeSeq EGFR, KRAS and BRAF Mutation Assays for research use. Investors may recall that this assay was designed for retrospective gene expression profiling (GEP) to complement traditional immunohistochemistry (IHC) testing, allowing investigators to assess mRNA expression of large numbers of biomarkers—up to 470 mRNA targets in this case—when formalin-fixed, paraffin-embedded (FFPE) sample availability is limited. Importantly, small and minimally invasive tissue biopsies are the trend nowadays in diagnostics, and within this setting, EdgeSeq PATH Assay allows for a more comprehensive profiling than conventional IHC. This may potentially lead to new GEP-based diagnostic or prognostic tests in oncology and beyond, in our view." (6/29/2017)

Who are some of HTG Molecular Diagnostics' key competitors?

Who are HTG Molecular Diagnostics' key executives?

HTG Molecular Diagnostics' management team includes the folowing people:

  • Ann F. Hanham Ph.D., Independent Chairman of the Board (Age 64)
  • Timothy B. Johnson, President, Chief Executive Officer, Director (Age 55)
  • Shaun D. McMeans, Vice President of Finance and Administration, Chief Financial Officer (Age 55)
  • Patrick C. Roche Ph.D., Senior Vice President - Research and Product Development (Age 64)
  • Debra A. Gordon Ph.D. J.D., Vice President, Chief Legal Counsel and Secretary (Age 57)
  • John L. Lubniewski, Chief Business Officer (Age 53)
  • Donnie M. Hardison, Director (Age 66)
  • Harry A. George, Independent Director (Age 68)
  • James T. LaFrance, Independent Director (Age 58)
  • Lee Roy McCracken, Independent Director (Age 59)

When did HTG Molecular Diagnostics IPO?

(HTGM) raised $50 million in an initial public offering (IPO) on Wednesday, May 6th 2015. The company issued 3,600,000 shares at $13.00-$15.00 per share. Leerink Partners acted as the underwriter for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Who owns HTG Molecular Diagnostics stock?

HTG Molecular Diagnostics' stock is owned by many different of institutional and retail investors. Top institutional investors include QIAGEN NV (13.10%) and Granahan Investment Management Inc. MA (3.33%). Company insiders that own HTG Molecular Diagnostics stock include Debra A Gordon, Holdings A/S Novo, John L Lubniewski, Patrick C Roche, Plc Glaxosmithkline, Shaun D Mcmeans and Tim B Johnson. View Institutional Ownership Trends for HTG Molecular Diagnostics.

Who bought HTG Molecular Diagnostics stock? Who is buying HTG Molecular Diagnostics stock?

HTG Molecular Diagnostics' stock was acquired by a variety of institutional investors in the last quarter, including Granahan Investment Management Inc. MA. View Insider Buying and Selling for HTG Molecular Diagnostics.

How do I buy HTG Molecular Diagnostics stock?

Shares of HTG Molecular Diagnostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HTG Molecular Diagnostics' stock price today?

One share of HTG Molecular Diagnostics stock can currently be purchased for approximately $1.89.

How big of a company is HTG Molecular Diagnostics?

HTG Molecular Diagnostics has a market capitalization of $23.63 million and generates $5.13 million in revenue each year. The medical research company earns $-26,030,000.00 in net income (profit) each year or ($2.55) on an earnings per share basis. HTG Molecular Diagnostics employs 85 workers across the globe.

How can I contact HTG Molecular Diagnostics?

HTG Molecular Diagnostics' mailing address is 3430 E. GLOBAL LOOP, TUCSON AZ, 85706. The medical research company can be reached via phone at 877-289-2615.


MarketBeat Community Rating for HTG Molecular Diagnostics (HTGM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  113 (Vote Outperform)
Underperform Votes:  95 (Vote Underperform)
Total Votes:  208
MarketBeat's community ratings are surveys of what our community members think about HTG Molecular Diagnostics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

HTG Molecular Diagnostics (NASDAQ:HTGM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.752.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.17$6.17$5.88$5.63
Price Target Upside: 175.30% upside175.30% upside155.43% upside35.22% upside

HTG Molecular Diagnostics (NASDAQ:HTGM) Consensus Price Target History

Price Target History for HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics (NASDAQ:HTGM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/8/2017HC WainwrightReiterated RatingBuy$6.00N/AView Rating Details
5/16/2017Rodman & RenshawBoost Price TargetBuy -> Buy$4.50 -> $6.00HighView Rating Details
4/19/2017Canaccord GenuityBoost Price TargetHold$5.50 -> $6.50LowView Rating Details
3/28/2016Leerink SwannReiterated RatingOutperform$10.00 -> $5.00N/AView Rating Details
(Data available from 12/10/2015 forward)

Earnings

HTG Molecular Diagnostics (NASDAQ:HTGM) Earnings History and Estimates Chart

Earnings by Quarter for HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics (NASDAQ HTGM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2017Q2($0.60)($0.60)$1.80 million$1.76 millionViewListenView Earnings Details
5/15/2017Q1($0.58)($0.73)$2.44 million$1.37 millionViewN/AView Earnings Details
11/14/2016Q3 2016($0.87)($0.92)$2.05 million$0.91 millionViewListenView Earnings Details
8/9/2016Q2($0.95)($0.98)$1.90 millionViewListenView Earnings Details
5/12/2016Q1($0.83)($1.02)$1.23 million$0.87 millionViewListenView Earnings Details
3/24/2016Q4($0.79)($0.83)$1.31 million$1.22 millionViewListenView Earnings Details
11/12/2015Q315($0.85)($0.76)$1.07 million$1.00 millionViewListenView Earnings Details
8/6/2015Q215($0.71)($1.73)$1.01 million$0.79 millionViewListenView Earnings Details
6/1/2015Q115($14.99)$1.00 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

HTG Molecular Diagnostics (NASDAQ:HTGM) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.1 EPS
Next Year EPS Consensus Estimate: $-1.18 EPS

Dividends

Dividend History for HTG Molecular Diagnostics (NASDAQ:HTGM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

HTG Molecular Diagnostics (NASDAQ HTGM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.60%
Institutional Ownership Percentage: 15.45%
Insider Trades by Quarter for HTG Molecular Diagnostics (NASDAQ:HTGM)
Insider Trades by Quarter for HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics (NASDAQ HTGM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/1/2017Shaun D McmeansVPSell945$2.11$1,993.95View SEC Filing  
11/1/2017Shaun D McmeansCFOSell945$2.26$2,135.70View SEC Filing  
10/16/2017Shaun D McmeansVPSell946$2.27$2,147.42View SEC Filing  
8/25/2017Holdings A/S NovoMajor ShareholderSell1,149,813$1.81$2,081,161.53View SEC Filing  
8/24/2017Holdings A/S NovoMajor ShareholderSell382,437$1.91$730,454.67View SEC Filing  
8/23/2017Holdings A/S NovoMajor ShareholderSell47,162$2.02$95,267.24View SEC Filing  
8/22/2017Holdings A/S NovoMajor ShareholderSell80,586$2.07$166,813.02View SEC Filing  
3/27/2017Plc GlaxosmithklineInsiderSell300,000$10.15$3,045,000.00View SEC Filing  
4/4/2016Debra A GordonVPSell1,672$2.89$4,832.08View SEC Filing  
4/4/2016John L LubniewskiInsiderSell796$2.89$2,300.44View SEC Filing  
4/4/2016Shaun D McmeansCFOSell1,601$2.89$4,626.89View SEC Filing  
4/4/2016Tim B JohnsonCEOSell4,914$2.89$14,201.46View SEC Filing  
3/14/2016Debra A GordonVPSell5,535$2.38$13,173.30View SEC Filing  
3/14/2016John L LubniewskiInsiderSell6,889$2.38$16,395.82View SEC Filing  
3/14/2016Patrick C RocheSVPSell5,929$2.38$14,111.02View SEC Filing  
3/14/2016Shaun D McmeansCFOSell5,651$2.38$13,449.38View SEC Filing  
3/14/2016Tim B JohnsonCEOSell10,621$2.38$25,277.98View SEC Filing  
3/9/2016Debra A GordonVPSell3,256$2.69$8,758.64View SEC Filing  
3/9/2016John L LubniewskiInsiderSell4,067$2.69$10,940.23View SEC Filing  
3/9/2016Patrick C RocheSVPSell3,491$2.69$9,390.79View SEC Filing  
3/9/2016Shaun D McmeansCFOSell3,325$2.69$8,944.25View SEC Filing  
3/9/2016Tim B JohnsonCEOSell6,299$2.69$16,944.31View SEC Filing  
8/24/2015Debra A GordonVPBuy1,000$5.16$5,160.00View SEC Filing  
8/18/2015Patrick C. RocheSVPBuy6,500$5.76$37,440.00View SEC Filing  
8/11/2015John L LubniewskiInsiderBuy5,000$7.67$38,350.00View SEC Filing  
5/11/2015A/S NovoMajor ShareholderBuy365,106$14.00$5,111,484.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

HTG Molecular Diagnostics (NASDAQ HTGM) News Headlines

Source:
DateHeadline
Should You Be Content With HTG Molecular Diagnostics Inc’s (HTGM) 34.3% Earnings Growth?Should You Be Content With HTG Molecular Diagnostics Inc’s (HTGM) 34.3% Earnings Growth?
finance.yahoo.com - December 6 at 8:46 AM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 5, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 5, 2017
finance.yahoo.com - December 5 at 6:03 PM
Zacks: Analysts Set $6.00 Target Price for HTG Molecular Diagnostics, Inc. (HTGM)Zacks: Analysts Set $6.00 Target Price for HTG Molecular Diagnostics, Inc. (HTGM)
www.americanbankingnews.com - December 2 at 11:30 PM
HTG Molecular Diagnostics, Inc. (HTGM) Upgraded to Buy at Zacks Investment ResearchHTG Molecular Diagnostics, Inc. (HTGM) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - November 25 at 9:32 AM
Should You Be Concerned About HTG Molecular Diagnostics Inc’s (HTGM) Investors?Should You Be Concerned About HTG Molecular Diagnostics Inc’s (HTGM) Investors?
finance.yahoo.com - November 21 at 7:42 PM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 20, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 20, 2017
finance.yahoo.com - November 20 at 8:05 PM
HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017
finance.yahoo.com - November 11 at 10:03 AM
HTG Molecular Diagnostics (HTGM) CEO TJ Johnson on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaHTG Molecular Diagnostics' (HTGM) CEO TJ Johnson on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 8 at 8:38 PM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 8, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 8, 2017
finance.yahoo.com - November 8 at 8:38 PM
46 Stocks Moving In Wednesdays Mid-Day Session - Benzinga46 Stocks Moving In Wednesday's Mid-Day Session - Benzinga
www.benzinga.com - November 8 at 3:35 PM
32 Stocks Moving In Wednesdays Pre-Market Session - Benzinga32 Stocks Moving In Wednesday's Pre-Market Session - Benzinga
www.benzinga.com - November 8 at 9:54 AM
HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings - GlobeNewswire (press release)HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings - GlobeNewswire (press release)
globenewswire.com - November 8 at 9:54 AM
HTG Molecular Diagnostics, Inc. to Host Earnings CallHTG Molecular Diagnostics, Inc. to Host Earnings Call
finance.yahoo.com - November 8 at 9:54 AM
HTG Molecular Diagnostics Reports 2017 Third Quarter EarningsHTG Molecular Diagnostics Reports 2017 Third Quarter Earnings
finance.yahoo.com - November 8 at 9:54 AM
HTG Molecular Diagnostics, Inc. (HTGM) Set to Announce Quarterly Earnings on MondayHTG Molecular Diagnostics, Inc. (HTGM) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - November 6 at 5:44 AM
HTG Molecular Diagnostics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Tuesday, November 7HTG Molecular Diagnostics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Tuesday, November 7
finance.yahoo.com - October 21 at 12:37 AM
HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference - GlobeNewswire (press release)HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference - GlobeNewswire (press release)
globenewswire.com - September 25 at 6:15 PM
HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare ConferenceHTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 25 at 10:04 AM
Should You Have HTG Molecular Diagnostics Inc’s (HTGM) In Your Portfolio?Should You Have HTG Molecular Diagnostics Inc’s (HTGM) In Your Portfolio?
finance.yahoo.com - September 23 at 9:36 AM
HTG Molecular Diagnostics (HTGM) Says it Was Issued Two Method ... - StreetInsider.comHTG Molecular Diagnostics (HTGM) Says it Was Issued Two Method ... - StreetInsider.com
www.streetinsider.com - September 20 at 8:22 PM
HTG Announces Issuance of Two Method Patents Related to its TechnologyHTG Announces Issuance of Two Method Patents Related to its Technology
finance.yahoo.com - September 20 at 8:22 PM
HTG Molecular Diagnostics (HTGM) Granted ISO 13485 Certification for Health Canada CMDCAS Requirements - StreetInsider.comHTG Molecular Diagnostics (HTGM) Granted ISO 13485 Certification for Health Canada CMDCAS Requirements - StreetInsider.com
www.streetinsider.com - September 20 at 12:41 AM
HTG Molecular Diagnostics (HTGM) Granted ISO 13485 Certification for Health Canada CMDCAS RequirementsHTG Molecular Diagnostics (HTGM) Granted ISO 13485 Certification for Health Canada CMDCAS Requirements
www.streetinsider.com - September 19 at 7:40 PM
BRIEF-HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirementsBRIEF-HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements
www.reuters.com - September 18 at 7:07 PM
HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS RequirementsHTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements
finance.yahoo.com - September 18 at 7:06 PM
HTG Molecular Diagnostics (HTGM) Buy Rating Reiterated at HC WainwrightHTG Molecular Diagnostics' (HTGM) Buy Rating Reiterated at HC Wainwright
www.americanbankingnews.com - September 17 at 10:58 PM
22 Stocks Moving In Thursdays Pre-Market Session | Benzinga - Benzinga22 Stocks Moving In Thursday's Pre-Market Session | Benzinga - Benzinga
www.benzinga.com - September 14 at 9:55 PM
HTG Molecular Diagnostics Provides Regulatory Update for its HTG EdgeSeq ALKPlus Assay - GlobeNewswire (press release)HTG Molecular Diagnostics Provides Regulatory Update for its HTG EdgeSeq ALKPlus Assay - GlobeNewswire (press release)
globenewswire.com - September 12 at 1:10 AM
HTG Molecular Diagnostics Provides Regulatory Update for its HTG EdgeSeq ALKPlus AssayHTG Molecular Diagnostics Provides Regulatory Update for its HTG EdgeSeq ALKPlus Assay
finance.yahoo.com - September 11 at 8:07 PM
HTG Molecular Diagnostics to Present at the Rodman & Renshaw 19th Annual Investment Conference - NasdaqHTG Molecular Diagnostics to Present at the Rodman & Renshaw 19th Annual Investment Conference - Nasdaq
www.nasdaq.com - September 7 at 12:37 AM
HTG Molecular Diagnostics to Present at the Rodman & Renshaw 19th Annual Investment ConferenceHTG Molecular Diagnostics to Present at the Rodman & Renshaw 19th Annual Investment Conference
finance.yahoo.com - September 6 at 7:36 PM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 31, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 31, 2017
finance.yahoo.com - August 31 at 7:34 PM
HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 5:57 AM
Insider Selling: HTG Molecular Diagnostics Inc (HTGM) Major Shareholder Sells 47,162 Shares of StockInsider Selling: HTG Molecular Diagnostics Inc (HTGM) Major Shareholder Sells 47,162 Shares of Stock
www.americanbankingnews.com - August 25 at 10:28 PM
Holdings A/S Novo Sells 1,149,813 Shares of HTG Molecular Diagnostics Inc (HTGM) StockHoldings A/S Novo Sells 1,149,813 Shares of HTG Molecular Diagnostics Inc (HTGM) Stock
www.americanbankingnews.com - August 25 at 10:28 PM
Holdings A/S Novo Sells 382,437 Shares of HTG Molecular Diagnostics Inc (HTGM) StockHoldings A/S Novo Sells 382,437 Shares of HTG Molecular Diagnostics Inc (HTGM) Stock
www.americanbankingnews.com - August 25 at 10:28 PM
HTG Molecular Diagnostics, Inc. (HTGM) Major Shareholder Sells $166,813.02 in StockHTG Molecular Diagnostics, Inc. (HTGM) Major Shareholder Sells $166,813.02 in Stock
www.americanbankingnews.com - August 22 at 10:20 PM
Contrasting Varex Imaging (VREX) and HTG Molecular Diagnostics (HTGM)Contrasting Varex Imaging (VREX) and HTG Molecular Diagnostics (HTGM)
www.americanbankingnews.com - August 21 at 10:22 PM
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Short Interest UpdateHTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Short Interest Update
www.americanbankingnews.com - August 13 at 2:20 AM
Reviewing HTG Molecular Diagnostics (NASDAQ:HTGM) and VAREX IMAGING (VREX)Reviewing HTG Molecular Diagnostics (NASDAQ:HTGM) and VAREX IMAGING (VREX)
www.americanbankingnews.com - August 12 at 12:12 PM
HTG Molecular Diagnostics Technology to be Used in WIN Consortium NSCLC Clinical Trial - GlobeNewswire (press release)HTG Molecular Diagnostics' Technology to be Used in WIN Consortium NSCLC Clinical Trial - GlobeNewswire (press release)
globenewswire.com - August 9 at 7:53 PM
HTG Molecular Diagnostics’ Technology to be Used in WIN Consortium NSCLC Clinical TrialHTG Molecular Diagnostics’ Technology to be Used in WIN Consortium NSCLC Clinical Trial
finance.yahoo.com - August 9 at 7:53 PM
Edited Transcript of HTGM earnings conference call or presentation 8-Aug-17 8:30pm GMTEdited Transcript of HTGM earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 9 at 7:53 PM
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Announces Quarterly  Earnings Results, Meets EstimatesHTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Announces Quarterly Earnings Results, Meets Estimates
www.americanbankingnews.com - August 9 at 7:48 PM
HTG Molecular Diagnostics (HTGM) CEO T. J. Johnson on Q2 2017 Results - Earnings Call TranscriptHTG Molecular Diagnostics' (HTGM) CEO T. J. Johnson on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 12:18 AM
HTG Molecular Diagnostics Reports Second Quarter 2017 Results - GlobeNewswire (press release)HTG Molecular Diagnostics Reports Second Quarter 2017 Results - GlobeNewswire (press release)
globenewswire.com - August 8 at 7:17 PM
HTG Molecular Diagnostics Reports Second Quarter 2017 ResultsHTG Molecular Diagnostics Reports Second Quarter 2017 Results
finance.yahoo.com - August 8 at 7:17 PM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 4, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 4, 2017
finance.yahoo.com - August 4 at 12:45 AM
Head to Head Survey: Cepheid (CPHD) and HTG Molecular Diagnostics (NASDAQ:HTGM)Head to Head Survey: Cepheid (CPHD) and HTG Molecular Diagnostics (NASDAQ:HTGM)
www.americanbankingnews.com - July 31 at 9:33 AM
HTG Molecular Diagnostics, Inc. (HTGM) Given a $6.00 Price Target at HC WainwrightHTG Molecular Diagnostics, Inc. (HTGM) Given a $6.00 Price Target at HC Wainwright
www.americanbankingnews.com - July 30 at 1:30 PM

SEC Filings

HTG Molecular Diagnostics (NASDAQ:HTGM) SEC Filings

DateFilerForm TypeView
12/01/2017
3:22 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2017
3:52 PM
George Harry A. (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/29/2017
3:40 PM
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing

Social Media

Financials

HTG Molecular Diagnostics (NASDAQ:HTGM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

HTG Molecular Diagnostics (NASDAQ HTGM) Stock Chart for Sunday, December, 10, 2017

Loading chart…

This page was last updated on 12/10/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.